(Q39192777)

9 September 2017

title

Labetalol in the treatment of hypertensive renal patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A26015

26 March 2022

author name string

J. G. Williams

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A26015

26 March 2022

K. De Voss

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A26015

26 March 2022

P. W. Craswell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A26015

26 March 2022

language of work or name

English

0 references

publication date

1 February 1978

1 reference

9 September 2017

25 February 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=26015

full work available at URL

26 March 2022

https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.1978.tb107854.x

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1978.TB107854.X

https://onlinelibrary.wiley.com/doi/full-xml/10.5694/j.1326-5377.1978.tb107854.x

26 March 2022

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1978.TB107854.X

Medical Journal of Australia

26 March 2022

published in

1 reference

9 September 2017

volume

1

1 reference

9 September 2017

issue

4

1 reference

9 September 2017

page(s)

225-228

1 reference

Alpha and beta adrenergic blockade in hypertension.

9 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1978.TB107854.X

Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension

26 March 2022

2

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1978.TB107854.X

Hemodynamic interference of alprenolol with dihydralazine in normal and hypertensive man

26 March 2022

3

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1978.TB107854.X

Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade

26 March 2022

4

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1978.TB107854.X

Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors

26 March 2022

5

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1978.TB107854.X

Preliminary studies of the pharmacological effects of 5-[1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)-ethyl] salicylamide (AH 5158) in man

26 March 2022

7

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1978.TB107854.X

Clinical investigation of an antagonist at alpha- and beta-adrenoceptors-AH5158A.

26 March 2022

8

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1978.TB107854.X

Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol

26 March 2022

9

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1978.TB107854.X

Estimation of Glomerular Filtration Rate from Plasma Clearance of 51-Chromium Edetic Acid

26 March 2022

13

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1978.TB107854.X

Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study

26 March 2022

14

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1978.TB107854.X

Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension

26 March 2022

15

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1978.TB107854.X

26 March 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=26015

24 October 2022

1 reference